Analysis of protein kinase C delta (PKCδ) expression in endometrial tumors

Human Pathology

Volumn 39, Issue 1, 2008, Pages 21-29

  Reno, Elaine M ^a   Haughian, James M ^a   Dimitrova, Irina K ^a   Jackson, Twila A ^a   Shroyer, Kenneth R ^a   Bradford, Andrew P ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Endometrial cancer; Expression; Immunohistochemistry; Nucleus; PKC

Indexed keywords

ETOPOSIDE; PROTEIN KINASE C DELTA;

ADULT; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CELL NUCLEUS; CYTOPLASM; ENDOMETRIUM; ENDOMETRIUM TUMOR; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOCARCINOMA; APOPTOSIS; CELL NUCLEUS; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROTEIN KINASE C-DELTA; TUMOR CELLS, CULTURED;

EID: 36749065508     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.05.023     Document Type: Article

References (37)

1. Amant F., Moerman P., Neven P., Timmerman D., Van Limbergen E., and Vergote I. Endometrial cancer. Lancet 366 (2005) 491-505
2. Nishizuka Y. The protein kinase C family and lipid mediators for transmembrane signaling and cell regulation. Alcohol Clin Exp Res 25 (2001) 3S-7S
3. Brodie C., and Blumberg P.M. Regulation of cell apoptosis by protein kinase C delta. Apoptosis 8 (2003) 19-27
4. Gutcher I., Webb P.R., and Anderson N.G. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 60 (2003) 1061-1070
5. Morse-Gaudio M., Connolly J.M., and Rose D.P. Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. Int J Oncol 12 (1998) 1349-1354
6. Musashi M., Ota S., and Shiroshita N. The role of protein kinase C isoforms in cell proliferation and apoptosis. Int J Hematol 72 (2000) 12-19
7. Bamberger A.M., Bamberger C.M., Wald M., Kratzmeier M., and Schulte H.M. Protein kinase C (PKC) isoenzyme expression pattern as an indicator of proliferative activity in uterine tumor cells. Mol Cell Endocrinol 123 (1996) 81-88
8. Fujimoto J., Hori M., Ichigo S., Morishita S., and Tamaya T. Clinical implication of fos and jun expressions and protein kinase activity in endometrial cancers. Eur J Gynaecol Oncol 16 (1995) 138-146
9. Connor P., Talavera F., Kang J.S., Burke J., Roberts J., and Menon K.M. Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A. Gynecol Oncol 67 (1997) 46-50
10. Kiley S.C., Clark K.J., Goodnough M., Welch D.R., and Jaken S. Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res 59 (1999) 3230-3238
11. Vucenik I., Ramakrishna G., Tantivejkul K., Anderson L.M., and Ramljak D. Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation. Breast Cancer Res Treat 91 (2005) 35-45
12. Evans J.D., Cornford P.A., Dodson A., Neoptolemos J.P., and Foster C.S. Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer. Am J Clin Pathol 119 (2003) 392-402
13. Koike K., Fujii T., Nakamura A.M., et al. Activation of protein kinase C delta induces growth arrest in NPA thyroid cancer cells through extracellular signal-regulated kinase mitogen-activated protein kinase. Thyroid 16 (2006) 333-341
14. Haughian J.M., Jackson T.A., Koterwas D.M., and Bradford A.P. Endometrial cancer cell survival and apoptosis is regulated by protein kinase C {alpha} and {delta}. Endocr Relat Cancer 13 (2006) 1251-1267
15. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
16. Basu A. Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med 7 (2003) 341-350
17. Tringler B., Liu W., Corral L., et al. B7-H4 overexpression in ovarian tumors. Gynecol Oncol 100 (2006) 44-52
18. Humphries M.J., Limesand K.H., Schneider J.C., Nakayama K.I., Anderson S.M., and Reyland M.E. Suppression of apoptosis in the protein kinase C delta null mouse in vivo. J Biol Chem 281 (2006) 9728-9737
19. Albitar L., Laidler L.L., Abdallah R., and Leslie K.K. Regulation of signaling phosphoproteins by epidermal growth factor and Iressa (ZD1839) in human endometrial cancer cells that model type I and II tumors. Mol Cancer Ther 4 (2005) 1891-1899
20. Fishman D.D., Segal S., and Livneh E. The role of protein kinase C in G1 and G2/M phases of the cell cycle. (Review). Int J Oncol 12 (1998) 181-186
21. Dempsey E.C., Newton A.C., Mochly-Rosen D., et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279 (2000) L429-L438
22. Goodnight J., Mischak H., and Mushinski J.F. Selective involvement of protein kinase C isozymes in differentiation and neoplastic transformation. Adv Cancer Res 64 (1994) 159-209
23. Gomez D.E., Skilton G., Alonso D.F., and Kazanietz M.G. The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis. (Review). Oncol Rep 6 (1999) 1363-1370
24. Fournier D.B., Chisamore M., Lurain J.R., Rademaker A.W., Jordan V.C., and Tonetti D.A. Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer. Gynecol Oncol 81 (2001) 366-372
25. D'Costa A.M., Robinson J.K., Maududi T., Chaturvedi V., Nickoloff B.J., and Denning M.F. The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas. Oncogene 25 (2006) 378-386
26. Langzam L., Koren R., Gal R., et al. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. Am J Clin Pathol 116 (2001) 377-385
27. Selzer E., Okamoto I., Lucas T., Kodym R., Pehamberger H., and Jansen B. Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage. Melanoma Res 12 (2002) 201-209
28. Balasubramanian N., Advani S.H., and Zingde S.M. Protein kinase C isoforms in normal and leukemic neutrophils: altered levels in leukemic neutrophils and changes during myeloid maturation in chronic myeloid leukemia. Leuk Res 26 (2002) 67-81
29. Tsai J.H., Hsieh Y.S., Kuo S.J., et al. Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma. Cancer Lett 161 (2000) 171-175
30. Jackson D.N., and Foster D.A. The enigmatic protein kinase C delta: complex roles in cell proliferation and survival. Faseb J 18 (2004) 627-636
31. Mischak H., Goodnight J.A., Kolch W., et al. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 268 (1993) 6090-6096
32. Yokoyama G., Fujii T., Tayama K., Yamana H., Kuwano M., and Shirouzu K. PKCdelta and MAPK mediate G(1) arrest induced by PMA in SKBR-3 breast cancer cells. Biochem Biophys Res Commun 327 (2005) 720-726
33. Kiley S.C., Clark K.J., Duddy S.K., Welch D.R., and Jaken S. Increased protein kinase C delta in mammary tumor cells: relationship to transformation and metastatic progression. Oncogene 18 (1999) 6748-6757
34. McCracken M.A., Miraglia L.J., McKay R.A., and Strobl J.S. Protein kinase C delta is a prosurvival factor in human breast tumor cell lines. Mol Cancer Ther 2 (2003) 273-281
35. DeVries T.A., Neville M.C., and Reyland M.E. Nuclear import of PKCdelta is required for apoptosis: identification of a novel nuclear import sequence. Embo J 21 (2002) 6050-6060
36. Iioka Y., Mishima K., Azuma N., et al. Overexpression of protein kinase C delta enhances cisplatin-induced cytotoxicity correlated with p53 in gastric cancer cell line. Pathobiology 72 (2005) 152-159
37. Mohanty S., Huang J., and Basu A. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1. Clin Cancer Res 11 (2005) 6730-6737